| Impact of Anti-Inflammatory Medication Use on Breast Cancer Incidence and Survival in Elderly ER+ Breast Cancer |
Adrian Lee |
University of Pittsburgh Medical Center |
PLCO |
Jan 28, 2021 |
PLCO-725 |
| Explainable Machine Learning for Personalized Decision-Making in Prostate Cancer |
Krithika Suresh |
University of Colorado |
PLCO |
Jan 28, 2021 |
PLCO-726 |
| Predicting Late Stage Cancer |
Paul Pinsky |
NCI |
PLCO |
Jan 25, 2021 |
PLCO-727 |
| Development of cell-free DNA (cfDNA) 5-hydroxymethylcytosine (5hmC) biomarkers for early detection of pancreatic ductal adenocarcinoma (PDAC) |
Marc Bissonnette |
University of Chicago |
PLCO |
Jan 15, 2021 |
2020-1003 |
| A systematic evaluation of dietary, hormoneļ¼ and behavioral factors associated with glioma risk |
Chuan Shao |
Chongqing General Hospital, Chongqing University |
PLCO |
Jan 14, 2021 |
PLCO-712 |
| Association between socioeconomic status and colorectal cancer survival in patients participating in the PLCO cancer screening trial |
Laura Davis |
Independent |
PLCO |
Jan 14, 2021 |
PLCO-714 |
| The impact of body mass index (BMI) on cancer screening |
Sonja Berndt |
National Cancer Institute |
PLCO |
Jan 14, 2021 |
PLCO-716 |
| Prospective metabolomics study of gastric cancer |
Xiang Shu |
Memorial Sloan Kettering Cancer Center |
PLCO |
Jan 13, 2021 |
2020-1017 |
| Generalizing the effect of chest x-ray screening |
Jon Steingrimsson |
Brown University |
PLCO |
Dec 31, 2020 |
PLCO-707 |
| Implication of new models for predicting lung cancer screening selection based on CT scan and pathology image data |
Yuan Luo |
Northwestern University |
PLCO |
Dec 31, 2020 |
PLCO-710 |
| Automated Medical Diagnostic Systems |
Fabien Scalzo |
University of California, Los Angeles (UCLA) |
PLCO |
Dec 29, 2020 |
PLCO-711 |
| Development of improved pre-diagnostic biomarker-based screening algorithms for ovarian cancer |
Anna Lokshin |
UPMC Hillman Cancer Center |
PLCO |
Dec 22, 2020 |
2020-1020 |
| Delineating the underlying reasons for the racial disparity in gastric cancer incidence in the United States. |
Haejin In |
Rutgers Cancer Institute |
PLCO |
Dec 22, 2020 |
2020-1002 |
| Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States |
Xuehong Zhang |
Harvard Medical School and Brigham and Women's Hospital |
PLCO |
Dec 22, 2020 |
2020-1001 |
| Updates in lethal prostate cancer in the PLCO trial |
Jonathan Shoag |
Weill Cornell Medicine |
PLCO |
Dec 21, 2020 |
PLCO-701 |
| Diabetes, antidiabetic medication use, and the risk of ovarian cancer |
Susan Steck |
University of South Carolina |
PLCO |
Dec 21, 2020 |
PLCO-705 |
| Diabetes risk reduction diet and all-cause and cause-specific mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Guo-Chao Zhong |
The Second Affiliated Hospital of Chongqing Medical University |
PLCO |
Dec 11, 2020 |
PLCO-700 |
| Genome-wide Association Study of Colorectal Cancer Using Penalized Orthogonal Components Regression |
Min Zhang |
Purdue University |
PLCO |
Dec 2, 2020 |
PLCO-697 |
| Dietary inflammatory index and colorectal carcinogenesis: a prospective cohort study |
Zhuyue Li |
Sichuan University |
PLCO |
Dec 2, 2020 |
PLCO-698 |
| HDoCS in PLCO: Health Disparities of Cancer Survivors in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Jacqueline Vo |
National Cancer Institute |
PLCO |
Dec 2, 2020 |
PLCO-696 |
